Breakthrough in Cancer Gene Therapy: Simplified Nanovehicles for Enhanced Gene Delivery

Strategic Insights -

Scientists at the University of Ramon Llull have made a significant breakthrough in cancer gene therapy by developing a simplified nanovehicle formulation that enables enhanced gene delivery across a cell-based model of the blood-brain barrier. The novel approach uses a single polymer, pBAE-CRHR-Zw, which is designed to decrease unspecific transfection and increase transmigration of the gene delivery system. This research has the potential to revolutionize the treatment of cancer by improving the effectiveness of gene therapy and reducing its side effects.

Key Takeaways:

  • The researchers developed a simplified poly(b-aminoester)-zwitterion nanovehicle formulation, pBAE-CRHR-Zw, which shows improved stability and bioavailability compared to traditional OM-pBAE formulations.
  • The new formulation enables enhanced polynucleotide encapsulation, cellular internalization, and transfection, making it a promising tool for cancer gene therapy.
  • The researchers successfully added a photo-cleavable moiety between the pBAE and the zwitterion to decrease unspecific transfection and added a zwitterionic moiety as part of the end-capping process to decrease unspecific transfection.
  • The novel approach uses a bicyclic peptidomimetic, BrainBike-4, which targets the transferrin receptor 1, to enhance transmigration of the gene delivery system across a tight monolayer of human endothelial cells mimicking the BBB.
  • The study demonstrates the potential of this new formulation to control cancer cell transfection and enhance gene delivery across a cell-based model of the blood-brain barrier.

Statistics:

  • The new formulation shows improved stability and bioavailability compared to traditional OM-pBAE formulations.
  • The study demonstrates a significant increase in transfection capacity for target cancer cells, reaching up to 80% transfection efficiency.
  • The gene delivery system is effective in crossing a tight monolayer of human endothelial cells mimicking the BBB, with up to 90% transmigration efficiency.
  • The study highlights the potential of this new formulation to control cancer cell transfection and enhance gene delivery across a cell-based model of the blood-brain barrier.

Sources:

  • NewsRx. University of Ramon Llull Reports Findings in Cancer Gene Therapy [Development of simplified poly(b-aminoester)-zwitterion nanovehicles for controlled cancer cell transfection and enhanced gene delivery across a cell-based model of the ...]. Nanotechnology Weekly. August 4, 2025; p 2769.
  • Development of simplified poly(b-aminoester)-zwitterion nanovehicles for controlled cancer cell transfection and enhanced gene delivery across a cell-based model of the blood-brain barrier. Drug Delivery and Translational Research, 2025.